5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOTIDE TRANSFORMYLASE-IMP CYCLOHYDROLASE FROM HUMAN CCRF-CEM LEUKEMIA-CELLS - PURIFICATION, PH-DEPENDENCE, AND INHIBITORS

被引:26
作者
SZABADOS, E
HINDMARSH, EJ
PHILLIPS, L
DUGGLEBY, RG
CHRISTOPHERSON, RI
机构
[1] UNIV SYDNEY,DEPT BIOCHEM,SYDNEY,NSW 2006,AUSTRALIA
[2] AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,CANBERRA,ACT 2601,AUSTRALIA
[3] UNIV QUEENSLAND,DEPT BIOCHEM,ST LUCIA,QLD 4071,AUSTRALIA
关键词
D O I
10.1021/bi00251a036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The bifunctional enzyme 5-aminoimidazole-4-carboxamide ribotide (AICAR) transformylase-IMP cyclohydrolase has been purified 780-fold to apparent homogeneity from human CCRF-CEM leukemia cells, completed with chromatography on Affi-Gel Blue followed by AICAR-Sepharose 4B. Using a sensitive radioassay, IMP cyclohydrolase has a K-s value for 5-formamidoimidazole-4-carboxamide ribotide (FAICAR) at pH 7.4 of 0.87 +/- 0.11 mu M. The following purine nucleotide derivatives were potent competitive inhibitors of IMP cyclohydrolase: 2-mercaptoinosine 5'-monophosphate (K-i = 0.094 +/- 0.024 mu M), xanthosine 5'-monophosphate (K-i = 0.12 +/- 0.01 mu M), 2-fluoroadenine arabinoside 5'-monophosphate (K-i = 0.16 +/- 0.02 mu M), 6-mercaptopurine riboside 5'-monophosphate (K-i = 0.20 +/- 0.02 mu M), adenosine N-1-oxide 5'-monophosphate (K-i = 0.28 +/- 0.03 mu M), and N-6-(carboxymethyl)adenosine 5'-monophosphate (K-i = 1.7 +/- 0.42 mu M). The pH dependencies of V-max and V-max/K-s IMP cyclohydrolase are consistent with a single ionizable amino acid residue (pK(a) = 7.57 +/- 0.09) of the enzyme which must be unprotonated for catalysis to occur and a residue (pK(a) = 7.57 +/- 0.14) which must be unprotonated for FAICAR to bind. The pK(a) values of 5.81 +/- 0.03 and 9.41 +/- 0.04 determined for FAICAR indicate that ionization of the substrate does not contribute significantly to the pH effects observed. Chemical modification of IMP cyclohydrolase provides evidence for arginine and cysteine residues at the active site, and roles for these residues in the mechanism of catalysis are proposed.
引用
收藏
页码:14237 / 14245
页数:9
相关论文
共 27 条
[1]   INHIBITION OF PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE TRANSFORMYLASE BY METHOTREXATE AND DIHYDROFOLIC ACID POLYGLUTAMATES [J].
ALLEGRA, CJ ;
DRAKE, JC ;
JOLIVET, J ;
CHABNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (15) :4881-4885
[2]  
ALLEGRA CJ, 1987, J BIOL CHEM, V262, P13520
[3]  
BROOKE J, 1990, CANCER RES, V50, P7793
[4]   THE PURINE ANALOGS - A THERAPEUTIC BEAUTY CONTEST [J].
CHESON, BD .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :352-355
[5]  
Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273
[7]  
ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405
[8]  
FLAKS JG, 1957, J BIOL CHEM, V224, P603
[9]  
FYFE JA, 1978, J BIOL CHEM, V253, P8721
[10]  
GORG A., 1985, SCI TOOLS, V32, P5